Korean Red Ginseng and Sarcopenia

The Effect of Korean Red Ginseng on Sarcopenia Biomarkers in Type 2 Diabetes Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004727

Enrollment

Registered

2020-02-11

Start date

2016-04-28

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : (Arm1)Two KRG extract tablets, each tablet containing 500 milligrams of KRG extract powder, were given twice a day after breakfast and dinner for 24 weeks, which is equivalent to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Persons who have passed 6 months or more after the diagnosis of diabetes

Exclusion criteria

Exclusion criteria: -Pregnant and lactating women -Patients with fluctuations in diabetes treatment within the last three months -More than 10% of glycated hemoglobin -Patients who have taken other herbal medicine in the last month -Others, who are considered difficult by the researcher to conduct this clinical trial (those who need an observer such as illiteracy or foreigner)

Design outcomes

Primary

Measure	Time frame
sarcopenia biomarkers	—

Secondary

Measure	Time frame
inflammatory and antioxidanat markers	—

Countries

Korea, Republic of

Contacts

Public ContactChul Woo Ahn

Yonsei University Health System, Gangnam Severance Hospital

Outcome results